BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Zygomycosis

Below is an extended Zygomycosis research listing. Click here to return to the Zygomycosis main in depth entry.

Recent Publications on Zygomycosis:

Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant.
BACKGROUND: The incidence of invasive fungal infections (IFIs) in solid...
Direct Link
25th September, 2008
Division of Infectious Diseases and International Health, Box 3035, Duke
Apophysomyces elegans - renal mucormycosis in a healthy host: a case report from south India. 24th September, 2008
Department of Urology, Christian Medical College, Vellore - 632 004, Tamil
Acute Wound Closure and Reconstruction Following Head Zygomycosis: Presentation of Two Cases and Review of Literature.
Zygomycosis is a rare but very aggressive fungal infection mainly seen in...
Direct Link
18th September, 2008
Section of Plastic and Reconstructive Surgery, University of Chicago,
In vitro activity of phenothiazines and their combinations with amphotericin B against Zygomycetes causing rhinocerebral zygomycosis.
The in vitro antifungal activities of two phenothiazine (PTZ) compounds,...
Direct Link
18th September, 2008
Department of Microbiology, Faculty of Science and Informatics, University
Primary cutaneous mucormycosis (zygomycosis) caused by Apophysomyces elegans. 18th September, 2008
Department of Dermatology, Apollo Hospital, Hyderabad, India.
Posaconazole for paediatric patients: status of development and future perspectives.
Posaconazole is a novel oral antifungal triazole with potent and...
Direct Link
9th September, 2008
Infectious Disease Research Program, Center for Bone Marrow
Iron overload and unique susceptibility of liver transplant recipients to disseminated disease due to opportunistic pathogens.
The propensity of liver transplant recipients to develop more fulminant...
Direct Link
30th August, 2008
School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Posaconazole: an oral triazole with an extended spectrum of activity.
OBJECTIVE: To summarize the published clinical data on posaconazole,...
Direct Link
21st August, 2008
Department of Pharmacy, Northwestern Memorial Hospital, Chicago, IL, USA.
A fatal case of cutaneous zygomycosis in a patient with severe metabolic acidosis.
We present a case of cutaneous zygomycosis in a patient with an...
Direct Link
19th August, 2008
Second Department of Medicine, Thriassio General Hospital, Athens, Greece.
Posaconazole combined with amphotericin B, an effective therapy for a murine disseminated infection caused by Rhizopus oryzae.
In a murine model of disseminated zygomycosis, low doses of amphotericin B...
Direct Link
13th August, 2008
Unitat de Microbiologia, Facultat de Medicina i Ciencies de la Salut,
Overview of opportunistic fungal infections in India. 12th August, 2008
Department of Medical Microbiology, Postgraduate Institute of Medical
Gastric zygomycosis in a pig affected with postweaning multisystemic wasting syndrome--case report. 2nd August, 2008
Central Agricultural Office, Veterinary Diagnostic Directorate, Budapest,
Post-transplant colonization with non-Aspergillus molds and risk of development of invasive fungal disease in lung transplant recipients.
BACKGROUND: The clinical significance and risk of progression to invasive...
Direct Link
29th July, 2008
Department of Medicine, Division of Infectious Diseases, University of
Syndromes of invasive fungal sinusitis.
Invasive fungal sinusitis should be suspected in immunocompromised or...
Direct Link
26th July, 2008
Department of Medicine, University of Mississippi Medical Center, Jackson,
Primary cutaneous mucormycosis in a lung transplant recipient: case report and concise review of the literature.
Mucormycosis (zygomycosis) is an invasive, opportunistic fungal infection...
Direct Link
17th July, 2008
Division of Infectious Diseases, University Health Network, University of
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional